GENE ONLINE|News &
Opinion
Blog

AstraZenca
Trials & Approvals RSV vaccines
The First Approved RSV Vaccine Worldwide Belongs to AstraZeneca and Sanofi
2022-11-06
Trials & Approvals AstraZeneca
AstraZeneca Welcomes Neurofibromatosis And Asthma Treatment Approvals in Japan
2022-09-28
Trials & Approvals COVID-19
AstraZeneca’s Treatment for COVID-19 Wins European Approval
2022-09-20
Trials & Approvals Chronic Kidney Disease
AstraZeneca’s Treatment for Chronic Kidney Disease Wins Yet Another Approval
2022-09-05
Trials & Approvals AstraZeneca
Japan Approves AstraZeneca’s Complement Inhibitor For Rare Muscle Disorder
2022-08-26
Trials & Approvals Breast Cancer
AstraZeneca and Merck’s HER2-negative Breast Cancer Treatment Wins Yet Another Approval
2022-08-25
M&A acquisition
Potential $1 billion Acquisition of TeneoTwo by AstraZeneca comes to Fruition
2022-08-11
M&A T-cellB-cell Lymphoma
AstraZeneca Buys TeneoTwo in $1.2 Billion T-Cell Engager Play
2022-07-06
Trials & Approvals Amyloidosis
AstraZeneca, Ionis’ ATTR Drug Edges Closer to US Approval With Latest Trial Win
2022-06-22
R&D Central Nervous System
New Study Reveals Hope for Recovery of Patients with Spinal Cord Injury
2022-05-27
COVID-19 COVID-19
AstraZeneca’s Covid-19 Booster and Antibody Cocktail Retains Neutralizing Ability against Omicron
2021-12-27
M&A Amyloidosis
AstraZeneca Acquires Caelum in $500m Deal to Strengthen Rare Diseases Division
2021-09-30
Trials & Approvals PARP Inhibitor
AZ, Merck’s PARP Inhibitor Shines in Phase 3 Prostate Cancer Trial
2021-09-26
Trials & Approvals Chronic Kidney Disease
FDA Okays Bayer’s Kidney Disease Drug, Kicking Off Market Rivalry Against Established SGLT-2 Inhibitors
2021-07-12
COVID-19 Monoclonal Antibody
Monoclonal Antibodies for COVID-19: AstraZeneca and Regeneron’s Therapies Endure Contrasting Fortunes
2021-06-16
1 2 3 … 5
LATEST
AbbVie Unveils Latest Data For Skyrizi In Difficult-To-Treat Psoriasis
2023-03-20
Sanofi Slashes Insulin Prices by Up to 78% Following Hot On the Heels of Major Competitors
2023-03-19
Novartis Snags Pediatric Brain Cancer Indication for Oncology Combination Therapy
2023-03-19
Pfizer, Astellas’ Prostate Cancer Drug Xtandi Achieves Goals In Phase 3
2023-03-19
Amgen Faces Class Action Lawsuit for Concealing $10.7 Billion Tax Bill to Manipulate Stock Price
2023-03-16
ImmunoPrecise Antibodies, Libera Bio Ink $155 Million Pact To Deliver Antibodies With Nanotechnology
2023-03-16
Dermavant Eyes Second Vtama Indication with Topline Atopic Dermatitis Results
2023-03-15
READ MORE
EVENT
2023-03-28
Reuters Events: Pharma USA 2023
Philadelphia, USA
2023-04-24
Cell & Gene Therapy Summit 2023
Brussels, Belgium
2023-04-28
Boston Chinese Investment Club 2023 Biotech Pitch Competition
Boston, USA
2023-11-16
3rd INTERNATIONAL CONFERENCE ON NUTRITION AND HEALTHCARE
Dubai, UAE
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2023 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top